THE POSSİBLE FACTORS THAT AFFECT THE CLINICAL SEVERITY AND MORTALITY OF COVİD PNEUMONIA

Barış Çil, Mehmet Kabak

Mardin State Hospital, Chest Diseases Department

Introduction: In 2019, an estimated 11.8 million people worldwide have been affected by coronavirus disease (COVID-19), with around 215.000 reported cases of COVID-19 infection in Turkey. At the time of this manuscript, there have been almost 571.000 COVID-19 associated deaths globally. The aim of this study was to investigate and present data regarding the clinical characteristics and outcomes of patients infected with COVID-19 virus in our hospital.

Materials and methods: This was a retrospective, descriptive, observational clinical study using cross-sectional data collected from confirmed COVID-19 patients in our institution. Patients were categorized into three groups based on the severity of the illness. Patients’ demographic andclinical characteristics, mortality rates, and the factors associated with mortality were analyzed.

Results: The study included 132 positive cases confirmed by the real-time PCR (RT-PCR). The mean age was 41±16 years. The disease was mild in 78.8 % of the cases and severe in 18.9%, with 2.3% being identified as critically ill. In-hospital mortality rate was 2.3 %. Age, WBC, lymphocytes, CURB-65, Sequential Organ Failure Assessment SOFAand quick SOFA scores, and C-reactive protein (CRP) were identified as factors associated with mortality.

Conclusion: Factors affecting mortality and clinical severity in covid-19 patients should be determined, this patient group should be followed up and treated carefully.Certain therapeutic interventions may lead to reduced mortality due to infection caused by the novel coronavirus.